New concepts of molecular biology on gastric carcinogenesis

Hepato-Gastroenterology

Volumn 52, Issue 64, 2005, Pages 1305-1312

  Kountouras, Jannis ^a,b   Zavos, Christos ^a   Chatzopoulos, Dimitrios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Department of Medicine ^*  (Greece)

Author keywords

Apoptosis; Epidemiology; Gastric cancer; Microsatellite instability; Oncogenes; Tumor suppressor genes

Indexed keywords

APC PROTEIN; CATENIN; PROTEIN P53; UVOMORULIN;

APOPTOSIS; ARTICLE; CANCER EPIDEMIOLOGY; CARCINOGENESIS; CARDIA; CELL ADHESION; COLON CANCER; COLON CARCINOGENESIS; DISEASE ACTIVITY; DISEASE COURSE; ENVIRONMENTAL FACTOR; FAMILY; GENE MUTATION; GENE OVEREXPRESSION; GENETIC PREDISPOSITION; HELICOBACTER PYLORI; HEREDITY; HUMAN; LOWER ESOPHAGUS SPHINCTER; MICROSATELLITE INSTABILITY; MOLECULAR BIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE;

CELL TRANSFORMATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MUTATION; ONCOGENES; STOMACH NEOPLASMS;

EID: 20044393654     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Torrado J, Santisteban A, Ruiz-Ederra J: Genetic susceptibility to gastric cancer. Hepatogastroenterology 2001; 48:1544-1547.
2. Koh TJ, Wang TC: Tumors of the stomach. In: Feldman M, Friedman LS, Sleisenger MH (Eds.). Sleisenger & Fordtran's Gastrointestinal and Liver Disease. Philadelphia: Saunders, 2002; pp. 829-855.
3. Ford JM: Inherited susceptibility to gastric cancer: advances in genetics and guidelines for clinical management. In: Perry MC (Ed.). American Society of Clinical Oncology: 2002 Educational book, 2002; pp. 116-125.
4. Mingchao, Devereux TR, Stockton P, Sun K, Sills RC, Clayton N, Portier M, Flake G: Loss of E-cadherin expression in gastric intestinal metaplasia and later stage p53 altered expression in gastric carcinogenesis. Exp Toxicol Pathol 2001; 53:237-246.
5. Kountouras J, Boura P, Lygidakis NJ: New concepts of molecular biology for colon carcinogenesis. Hepatogastroenterology 2000; 47:1291-1297.
6. Fiocca R, Luinetti O, Villani L, Mastracci L, Quilici P, Grillo F, Ranzani GN: Molecular mechanisms involved in the pathogenesis of gastric carcinoma: interactions between genetic alterations, cellular phenotype and cancer histotype. Hepatogastroenterology 2001; 48:1523-1530.
7. Tamura G: Genetic and epigenetic alterations of tumor suppressor and tumor-related genes in gastric cancer. Histol Histopathol 2002; 17:323-329.
8. Unger Z, Molnar B, Pronai L, Szaleczky E, Zagoni T, Tulassay Z: Mutant p53 expression and apoptotic activity of Helicobacter pylori positive and negative gastritis in correlation with the presence of intestinal metaplasia. Eur J Gastroenterol Hepatol 2003; 15:389-393.
9. Joo YE, Sohn YH, Joo SY, Lee WS, Min SW, Park CH, Rew JS, Choi SK, Park CS, Kim YJ, Kim SJ: The role of vascular endothelial growth factor (VEGF) and p53 status for angiogenesis in gastric cancer. Korean J Intern Med 2002; 17:211-219.
10. Feng CW, Wang LD, Jiao LH, Liu B, Zheng S, Xie XJ: Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. BMC Cancer 2002; 2:8.
11. Suriano G, Oliveira C, Ferreira P, Machado JC, Bordin MC, De Wever O, Bruyneel EA, Moguilevsky N, Grehan N, Porter TR, Richards FM, Hruban RH, Roviello F, Huntsman D, Mareel M, Carneiro F, Caldas C, Seruca R: Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum Mol Genet 2003; 12:575-582.
12. Ebert MP, Fei G, Kahmann S, Muller O, Yu J, Sung JJ, Malfertheiner P: Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer. Carcinogenesis 2002; 23:87-91.
13. Myung N, Kim MR, Chung IP, Kim H, Jang JJ: Loss of p16 and p27 is associated with progression of human gastric cancer. Cancer Lett 2000; 153:129-136.
14. Tsujie M, Yamamoto H, Tomita N, Sugita Y, Ohue M, Sakita I, Tamaki Y, Sekimoto M, Doki Y, Inoue M, Matsuura N, Monden T, Shiozaki H, Monden M: Expression of tumor suppressor gene p16(INK4) products in primary gastric cancer. Oncology 2000; 58:126-136.
15. Kyrlagkitsis I, Karamanolis DG: Genes and gastric cancer. Hepatogastroenterology 2004; 51:320-327.
16. Candusso ME, Luinetti O, Villani L, Alberizzi P, Klersy C, Fiocca R, Ranzani GN, Solcia E: Loss of heterozygosity at 18q21 region in gastric cancer involves a number of cancer-related genes and correlates with stage and histology, but lacks independent prognostic value. J Pathol 2002; 197:44-50.
17. Konturek PC, Kania J, Kukharsky V, Ocker S, Hahn EG, Konturek SJ: Influence of gastrin on the expression of cyclooxygenase-2, hepatocyte growth factor and apoptosis-related proteins in gastric epithelial cells. J Physiol Pharmacol 2003; 54:17-32.
18. Wang TC, Dangler CA, Chen D, Goldenring JR, Koh T, Raychowdhury R, Coffey RJ, Ito S, Varro A, Dockray GJ, Fox JG: Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000; 118:36-47.
19. Kountouras J, Chatzopoulos D, Zavos C: Reactive oxygen metabolites and upper gastrointestinal diseases. Hepatogastroenterology 2001; 48:743-701.
20. Guo XL, Wang LE, Du SY, Fan CL, Li L, Wang P, Yuan Y: Association of cyclooxygenase-2 expression with Hp-cagA infection in gastric cancer. World J Gastroenterol 2003; 9:246-249.
21. Seo JH, Kim H, Kim KH: Cyclooxygenase-2 expression by transcription factors in Helicobacter pylori-infected gastric epithelial cells: comparison between HP 99 and NCTC 11637. Ann N Y Acad Sci 2002; 973:477-480.
22. Takafuji VA, Evans A, Lynch KR, Roche JK: PGE(2) receptors and synthesis in human gastric mucosa: perturbation in cancer. Prostaglandins Leukot Essent Fatty Acids 2002; 66:71-81.
23. Chen JH, Liu TY, Wu CW, Chi CW: Nonsteroidal anti-inflammatory drugs for treatment of advanced gastric cancer: cyclooxygenase-2 is involved in hepatocyte growth factor mediated tumor development and progression. Med Hypotheses 2001; 57:503-505.
24. Wong BC, Jiang X, Fan XM, Lin MC, Jiang SH, Lam SK, Kung HF: Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer. Oncogene 2003; 22:1189-1197.
25. Churin Y, Al-Ghoul L, Kepp O, Meyer TF, Birchmeier W, Naumann M: Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J Cell Biol 2003; 161:249-255.
26. Amemiya H, Kono K, Mori Y, Takahashi A, Ichihara F, Iizuka H, Sekikawa T, Matsumoto Y: High frequency of c-Met expression in gastric cancers producing alpha-fetoprotein. Oncology 2000; 59:145-151.
27. Niki M, Isozaki H, Toyoda M, Ishibashi T, Fujii K, Nomura E, Mabuchi H, Nakamura M, Nishiguchi K, Tanigawa N: Serum human hepatocyte growth factor (hHGF) is elevated in patients with metastatic gastric carcinoma. Hepatogastroenterology 1999; 46:568-573.
28. Kim HK, Song KS, Park YS, Kang YH, Lee YJ, Lee KR, Kim HK, Ryu KW, Bae JM, Kim S: Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 2003; 39:184-191.
29. Heidemann J, Ogawa H, Dwinell MB, Rafiee P, Maaser C, Gockel HR, Otterson MF, Ota DM, Lugering N, Domschke W, Binion DG: Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J Biol Chem 2003; 278:8508-8515.
30. Kido S, Kitadai Y, Hattori N, Haruma K, Kido T, Ohta M, Tanaka S, Yoshihara M, Sumii K, Ohmoto Y, Chayama K: Interleukin 8 and vascular endothelial growth factor - prognostic factors in human gastric carcinomas? Eur J Cancer 2001; 37:1482-1487.
31. Takahashi R, Tanaka S, Kitadai Y, Sumii M, Yoshihara M, Haroma K, Chayama K: Expression of vascular endothelial growth factor and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncology 2003; 64:266-274.
32. Matsumoto K, Konno H, Tanaka T, Baba M, Kanai T, Kamiya K, Ohba K, Nakamura S: Combination therapy with vascular endothelial growth factor neutralizing, antibody and mitomycin C on human gastric cancer xenograft. Jpn J Cancer Res 2000; 91:748-752.
33. Fang DC, Wang RQ, Yang SM, Yang JM, Liu HF, Peng GY, Xiao TL, Luo YH: Mutation and methylation of hMLH1 in gastric carcinomas with microsatellite instability. World J Gastroenterol 2003; 9:655-659.
34. Lee TL, Leung WK, Lau JY, Tong JH, Ng EK, Chan FK, Chung SC, Sung JJ, To KF: Inverse association between cyclooxygenase-2 overexpression and microsatellite instability in gastric cancer. Cancer Lett 2001; 168:133-140.
35. Theuer CP, Campbell BS, Peel DJ, Lin F, Carpenter P, Ziogas A, Butler JA: Microsatellite instability in Japanese vs European American patients with gastric cancer. Arch Surg 2002; 137:960-965.
36. Schwarz A: Preventive gastrectomy in patients with gastric cancer risk due to genetic alterations of the E-cadherin gene defect. Langenbecks Arch Surg 2003; 388:27-32.
37. Oliveira C, Seruca R, Caldas C: Genetic screening for hereditary diffuse gastric cancer. Expert Rev Mol Diagn 2003; 3:201-215.
38. Lim S, Lee HS, Kim HS, Kim YI, Kim WH: Alteration of E-cadherin-mediated adhesion protein is common, but microsatellite instability is uncommon in young age gastric cancers. Histopathology 2003; 42:128-136.
39. Sehouli J, Mustea A, Konsgen D, Katsares I, Lichtenegger W: Polymorphism of IL-1 receptor antagonist gene: role in cancer. Anticancer Res 2002; 22:3421-3424.
40. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, Fraumeni JF Jr, Chow WH: Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124:1193-1201.
41. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H: Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002; 123:92-105.